Described herein are pharmaceutical packaging devices which stop oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-sensitive medicines, these types of techniques including a syringe with an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging with extremely small permeability to oxyge